Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-21-020548

Director sold 18,000 shares at $35.02 ($630,360)

  • Director acquired 18,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KEARNS THOMAS F JR · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-11 Exercise or conversion : show line 1 in the form +18,000 $3.50 $63,000 166,164 D
2021-03-11 Sale : show line 2 in the form −18,000 $35.02 $630,360 148,164 D
Open-market sales · 18,000 sh · avg $35.02 · $630,360

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-03-11 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −12,000 0 D
2021-03-11 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −6,000 0 D
Loading xslF345X03/doc4.xml…